Improving MRI techniques for brain tumor assessment
One-shot morphologic, hemodynamic and metabolic MR imaging of brain tumors
This study is testing a new MRI method that uses just one contrast agent to give doctors a clearer picture of brain tumors, including their structure and blood flow, making it easier and more comfortable for patients to get the information they need for better treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10680562 on NIH RePORTER |
What this research studies
This research aims to develop a new MRI technique that uses a single contrast agent to provide detailed information about brain tumors' structure, blood flow, and metabolism. By combining multiple imaging parameters into one procedure, it seeks to enhance the efficiency and comfort of brain tumor evaluations. The approach addresses the challenge of detecting tumor hypoxia, which can affect treatment outcomes, by eliminating the need for multiple scans and injections. This could lead to better management of brain tumors and improved patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with brain tumors who require imaging for treatment planning or monitoring.
Not a fit: Patients with non-brain tumors or those who do not require MRI imaging for their condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient assessments of brain tumors, ultimately improving treatment planning and patient outcomes.
How similar studies have performed: Previous research has shown promise in using advanced MRI techniques for tumor assessment, indicating potential for success in this novel approach.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Kodibagkar, Vikram D. — Arizona State University-Tempe Campus
- Study coordinator: Kodibagkar, Vikram D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.